Literature DB >> 15956553

Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.

Keigo Machida1, Kevin T-H Cheng, Nicole Pavio, Vicky M-H Sung, Michael M C Lai.   

Abstract

Hepatitis C virus (HCV) is one of the leading causes of chronic liver diseases and B-lymphocyte proliferative disorders, including mixed cryoglobulinemia and B-cell lymphoma. It has been suggested that HCV infects human cells through the interaction of its envelope glycoprotein E2 with a tetraspanin molecule CD81, the putative viral receptor. Here, we show that the engagement of B cells by purified E2 induced double-strand DNA breaks specifically in the variable region of immunoglobulin (V(H)) gene locus, leading to hypermutation in the V(H) genes of B cells. Other gene loci were not affected. Preincubation with the anti-CD81 monoclonal antibody blocked this effect. E2-CD81 interaction on B cells triggered the enhanced expression of activation-induced cytidine deaminase (AID) and also stimulated the production of tumor necrosis factor alpha. Knockdown of AID by the specific small interfering RNA blocked the E2-induced double-strand DNA breaks and hypermutation of the V(H) gene. These findings suggest that HCV infection, through E2-CD81 interaction, may modulate host's innate or adaptive immune response by activation of AID and hypermutation of immunoglobulin gene in B cells, leading to HCV-associated B-cell lymphoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956553      PMCID: PMC1143751          DOI: 10.1128/JVI.79.13.8079-8089.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota.

Authors:  Ahmad Faili; Said Aoufouchi; Eric Flatter; Quentin Guéranger; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Nature       Date:  2002-10-31       Impact factor: 49.962

Review 2.  Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity.

Authors:  F Nina Papavasiliou; David G Schatz
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

3.  DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase.

Authors:  Hitoshi Nagaoka; Satomi Ito; Masamichi Muramatsu; Mikiyo Nakata; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

Authors:  M Flint; C Maidens; L D Loomis-Price; C Shotton; J Dubuisson; P Monk; A Higginbottom; S Levy; J A McKeating
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance.

Authors:  Fang Wu; Xinjian Lin; Tsuyoshi Okuda; Stephen B Howell
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

6.  AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line.

Authors:  Ahmad Faili; Said Aoufouchi; Quentin Guéranger; Carole Zober; Anne Léon; Barbara Bertocci; Jean-Claude Weill; Claude-Agnès Reynaud
Journal:  Nat Immunol       Date:  2002-07-29       Impact factor: 25.606

7.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.

Authors:  Svend K Petersen-Mahrt; Reuben S Harris; Michael S Neuberger
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

8.  Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase.

Authors:  Javier Di Noia; Michael S Neuberger
Journal:  Nature       Date:  2002-07-31       Impact factor: 49.962

9.  The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process.

Authors:  F Nina Papavasiliou; David G Schatz
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

10.  DNA double-strand breaks: prior to but not sufficient in targeting hypermutation.

Authors:  Linda Bross; Masamichi Muramatsu; Kazuo Kinoshita; Tasuku Honjo; Heinz Jacobs
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  57 in total

1.  Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.

Authors:  Hiroyoshi Doi; Tara K Iyer; Erica Carpenter; Hong Li; Kyong-Mi Chang; Robert H Vonderheide; David E Kaplan
Journal:  Hepatology       Date:  2012-01-19       Impact factor: 17.425

Review 2.  Hepatitis C virus and lymphoma.

Authors:  D S Viswanatha; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

3.  Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection.

Authors:  L Meroni; L Milazzo; B Menzaghi; R Mazzucchelli; D Mologni; P Morelli; V Broggini; F Adorni; M Galli; A Riva
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

4.  Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.

Authors:  Jill E Roughan; Kathryn M Reardon; Kristin E Cogburn; Heribert Quendler; Paul J Pockros; Mansun Law
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

Review 5.  Role of hepatitis C virus in B cell lymphoproliferations.

Authors:  Felicia Tucci; Ralf Küppers
Journal:  Virol Sin       Date:  2014-02       Impact factor: 4.327

6.  CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas.

Authors:  Robert F Luo; Shuchun Zhao; Robert Tibshirani; June H Myklebust; Mrinmoy Sanyal; Rosemary Fernandez; Dita Gratzinger; Robert J Marinelli; Zhi Shun Lu; Anna Wong; Ronald Levy; Shoshana Levy; Yasodha Natkunam
Journal:  Hum Pathol       Date:  2009-12-08       Impact factor: 3.466

7.  Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.

Authors:  Silvia de Sanjose; Yolanda Benavente; Claire M Vajdic; Eric A Engels; Lindsay M Morton; Paige M Bracci; John J Spinelli; Tongzhang Zheng; Yawei Zhang; Silvia Franceschi; Renato Talamini; Elizabeth A Holly; Andrew E Grulich; James R Cerhan; Patricia Hartge; Wendy Cozen; Paolo Boffetta; Paul Brennan; Marc Maynadié; Pierluigi Cocco; Ramon Bosch; Lenka Foretova; Anthony Staines; Nikolaus Becker; Alexandra Nieters
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04       Impact factor: 11.382

Review 8.  Hepatitis C virus-induced cryoglobulinemia.

Authors:  Edgar D Charles; Lynn B Dustin
Journal:  Kidney Int       Date:  2009-07-15       Impact factor: 10.612

Review 9.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

10.  Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.

Authors:  Korenori Ohtsubo; Michio Sata; Takumi Kawaguchi; Satoshi Morishige; Yuka Takata; Eijiro Oku; Rie Imamura; Ritsuko Seki; Michitoshi Hashiguchi; Koichi Osaki; Kazuaki Yakushiji; Taisuke Kanaji; Kohji Yoshimoto; Takato Ueno; Takashi Okamura
Journal:  Int J Hematol       Date:  2009-04-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.